Trial intelligence / Profile preview

Dexmedetomidine vs Melatonin vs Pregabalin for Hypotensive Anesthesia in FESS

NCT05829148Phase 1Unknown

Sponsor
Egymedicalpedia
Start
May 2023
Primary completion
Nov 2024
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, single-blind trial of dexmedetomidine, melatonin and pregabalin in chronic rhinosinusitis (CRS) (4 arms), sponsored by Egymedicalpedia. Primary endpoint: Pain Relieve. Status: unknown.

02

Drugs

dexmedetomidinemelatoninpregabalin
03

Conditions

chronic rhinosinusitis (CRS)

Beyond the preview

Go deeper on NCT05829148.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05829148.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call